Skip to main navigation menu Skip to main content Skip to site footer

Articles

Vol. 2 No. 2 (2011): April – June 2011

Synthesis and Chemical Characterisation of Some Novel Substituted Flavone’s for It’s Anti Microbial Activity

DOI
https://doi.org/10.37285/ijddd.2.2.9
Submitted
November 28, 2024
Published
2024-12-08

Abstract

The present study reports an experiment on some derivatives of 2-phenyl-chromen-4-one (flavone ring) have a proven inhibitory activity against a variety of human pathogens, including antibiotic-resistant Gram-positive and Gram-negative bacteria and antifungal activities screened against four human pathogenic bacteria and two phytopathogenic fungi. Flavanoid derivatives have been made through Algar– Flynn–Oyamada reaction from hydroxyacetophenones and aromatic-aldehydes. The structures of the synthesized compounds were elucidated by UV, IR and 1H NMR spectroscopic techniques, and elemental analysis. These compounds are potentially useful pharmacologically active compounds and are studied for biological activities like antibacterial and antifungal screens performed in vitro by the plate-hole diffusion method.

References

  1. [1] J.H.Block In WilsonGisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, Lippincott Williams & Wilkins, 2004, pp 1-2.
  2. [2] Soon Sung Lim; Hye-sook Kim and Dong-Ung Lee, Bull Korean Chemical Society, 2007, 28, 2495-2497.
  3. [3] C.G.Wermuth, In The Practice of Medicinal Chemistry, Elsivier, 2004, pp 23.
  4. [4] Ji Jun Xue, Xian shu Zhang, Xi Zhou Liang, Ying Li, Chinese Chemical Letters, 2003, 14, 443-444.
  5. [5] W.C.Evans, Trease and Evans Pharmacognosy, Harcourt Publisher’s Ltd, 2002, 512, 246-247.
  6. [6] Valeria-Marta Gorduza; Corneliu Tarabasanu-Mihaila; Vlad Gorduza; Corina Cernatescu; Manuela Rusu, Ovidus University Annals of Chemistry, 2000, 11, 56-59.
  7. [7] M.A.Alvarez; N.B.Debattista; N.B.Pappano, Folia Microbiology, 2008, 23-28.
  8. [8] Peng, Wen-Jie; Han Xiu-Wen; Yu Biao, Chinese Journal of Chemistry, 2006, 24, 1154-1162.
  9. [9] Y.Rajendra Prasad; A.Lakshmana Rao; R.Rambabu, E-Journal of Chemistry, 2008, 461-462.
  10. [10] Joanne Barnes; Linda A. Anderson, In Herbal Medicines, Pharmaceutical Press, 2002, pp 507.
  11. [11] L.L.Brunton; J.S. Lazo, In Goodman & Gilman’s-The Pharmacological Basis of Therapeutics, Mc-Graw Hill Companies, pp 1542, 1551, 1513.
  12. [12] H.Goker; G.Ayhan; M.Tuncbilek; R.Ertan; G.Leoncini;R. Garzoglio; M.Mazzei, European Journal of Medicinal Chemistry, 1995, 30, 561-567.
  13. [13] W.Bylka; I.Matlawska; N.A.Pilewski, Journal of American Nutritional Association, 2004, 7, 2, 24-31.
  14. [14] Sayed Alam, Journel of Chemical Science, 2004, 116(6),325-331.
  15. [15] D.Tsimogiannis; S.Martina; G. Panayotou; V.Oreopoulou, Molecules, 2007, 12, 593-606.

Similar Articles

<< < 1 2 3 

You may also start an advanced similarity search for this article.